Search
Now showing items 1-6 of 6
Chitosan: a versatile bio-platform for breast cancer theranostics
(ELSEVIER, 2022)
Breast cancer is considered one of the utmost neoplastic diseases globally, with a high death rate of patients. Over the last decades, many approaches have been studied to early diagnose and treat it, such as chemotherapy, ...
Gold nanorods for drug and gene delivery: an overview of recent advancements
(2022)
Over the past few decades, gold nanomaterials have shown great promise in the field of nanotechnology, especially in medical and biological applications. They have become the most used nanomaterials in those fields due to ...
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
(Elsevier, 2022)
Normal cells depend on autophagy to maintain cellular homeostasis by recycling damaged organelles and misfolded proteins and degrading toxic agents. Similar to apoptosis, targeting autophagy has been under attention in ...
(Nano)platforms in bladder cancer therapy: Challenges and opportunities
(John Wiley and Sons Inc, 2022)
Urological cancers are among the most common malignancies around the world. In particular, bladder cancer severely threatens human health due to its aggressive and heterogeneous nature. Various therapeutic modalities have ...
Customizing nano-chitosan for sustainable drug delivery
(PMC, 2022)
Chitosan is a natural polymer with acceptable biocompatibility, biodegradability, and mechanical stability; hence, it has been widely appraised for drug and gene delivery applications. However, there has been no comprehensive ...
Advances in aptamer-based drug delivery vehicles for cancer therapy
(Elsevier, 2022)
Overall, aptamers are special classes of nucleic acid-based macromolecules that are beginning to investigate because of their capability of avidity binding to a specific target for clinical use. Taking advantage of ...